AGILE THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Agile Therapeutics Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
  • Agile Therapeutics Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 6.9M shares, a 321% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 6.9M +5.26M +321% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 6.86M +5.92M +636% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.96M +2.1M +245% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 2.28M -36.7M -94.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.64M -10.7M -86.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 932K -2.43M -72.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 859K -2.18M -71.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 39M -55.7M -58.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 12.4M -80.6M -86.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 3.37M -84.9M -96.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 3.03M -84.5M -96.5% Dec 31, 2021 10-K 2023-03-23
Q3 2021 94.7M +7.29M +8.34% Sep 30, 2021 10-Q/A 2021-12-30
Q2 2021 92.9M +5.63M +6.45% Jun 30, 2021 10-Q 2021-07-26
Q1 2021 88.3M +1.05M +1.21% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 87.6M +17.8M +25.4% Dec 31, 2020 10-K 2022-03-30
Q3 2020 87.4M +28.1M +47.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 87.3M +42.7M +95.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 87.2M +43.6M +100% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 69.8M +35.4M +103% Dec 31, 2019 10-K 2021-03-01
Q3 2019 59.3M +24.9M +72.5% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 44.6M +10.3M +29.8% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 43.6M +9.37M +27.4% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 34.4M +191K +0.56% Dec 31, 2018 10-K 2020-02-20
Q3 2018 34.4M +219K +0.64% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 34.4M +5.57M +19.3% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 34.2M +5.47M +19% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 34.2M +5.43M +18.9% Dec 31, 2017 10-K 2019-03-12
Q3 2017 34.2M +5.4M +18.8% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 28.8M +53.7K +0.19% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 28.8M +38.3K +0.13% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 28.8M +6.44M +28.9% Dec 31, 2016 10-K 2018-03-12
Q3 2016 28.8M +6.47M +29% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 28.8M +6.51M +29.3% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 28.7M +6.58M +29.7% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 22.3M +3.68M +19.8% Dec 31, 2015 10-K 2017-03-15
Q3 2015 22.3M +3.7M +19.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 22.2M +3.65M +19.6% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 22.2M Mar 31, 2015 10-Q 2015-05-12
Q4 2014 18.6M +18.5M +17898% Dec 31, 2014 10-K 2016-03-09
Q3 2014 18.6M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 18.6M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 104K Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.